REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 202 filers reported holding REATA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $643,000 | +54.6% | 25,600 | +86.9% | 0.00% | +50.0% |
| Q2 2022 | $416,000 | -55.3% | 13,700 | +48.3% | 0.00% | -33.3% |
| Q3 2021 | $930,000 | -32.7% | 9,235 | -5.5% | 0.00% | -40.0% |
| Q2 2021 | $1,382,000 | -63.7% | 9,768 | -74.4% | 0.01% | -70.6% |
| Q1 2021 | $3,803,000 | +37.6% | 38,140 | +70.6% | 0.02% | +41.7% |
| Q4 2020 | $2,764,000 | -25.7% | 22,355 | -48.7% | 0.01% | -14.3% |
| Q1 2019 | $3,722,000 | -5.6% | 43,543 | -38.1% | 0.01% | -22.2% |
| Q4 2018 | $3,944,000 | – | 70,300 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
| Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
| Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
| Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
| MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
| Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
| Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
| Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |